4534 — Mochida Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00- ¥105bn
- ¥54bn
- ¥105bn
- 94
- 69
- 72
- 93
Annual cashflow statement for Mochida Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | — | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 11,900 | 14,591 | 9,044 | 6,160 | 8,052 |
| Depreciation | |||||
| Non-Cash Items | 305 | 127 | -760 | -439 | 409 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -5,751 | -9,947 | -3,659 | -16,009 | -2,047 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 9,196 | 7,460 | 7,297 | -7,480 | 9,354 |
| Capital Expenditures | -1,935 | -2,988 | -2,166 | -2,296 | -2,160 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 1,055 | 981 | -783 | 2,370 | 19,515 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -880 | -2,007 | -2,949 | 74 | 17,355 |
| Financing Cash Flow Items | -1 | 0 | 0 | -14 | -27 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | -5,112 | -5,956 | -6,884 | -6,393 | -2,865 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3,195 | -472 | -2,504 | -13,720 | 23,860 |